Exelon (NASDAQ:EXC) Updates FY 2022 Earnings Guidance

Exelon (NASDAQ:EXCGet Rating) issued an update on its FY 2022 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $2.18-$2.32 for the period, compared to the consensus estimate of $2.26. The company issued revenue guidance of -.

EXC has been the topic of several recent analyst reports. The Goldman Sachs Group cut shares of Exelon from a buy rating to a neutral rating and cut their price target for the company from $62.00 to $44.00 in a report on Friday, February 4th. Mizuho upgraded shares of Exelon from a neutral rating to a buy rating and upped their price target for the stock from $43.00 to $46.00 in a research report on Friday, March 11th. BMO Capital Markets decreased their target price on shares of Exelon from $63.00 to $47.00 in a research report on Thursday, February 17th. Royal Bank of Canada downgraded shares of Exelon from an outperform rating to a sector perform rating and cut their price target for the company from $66.00 to $46.00 in a report on Thursday, February 3rd. Finally, Vertical Research lowered shares of Exelon from a buy rating to a hold rating and set a $45.00 price objective for the company. in a research note on Thursday, February 3rd. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Exelon currently has an average rating of Hold and a consensus price target of $48.17.

NASDAQ EXC opened at $46.73 on Monday. The stock has a market capitalization of $45.80 billion, a price-to-earnings ratio of 17.63, a PEG ratio of 3.32 and a beta of 0.57. The stock’s 50 day moving average price is $46.72 and its two-hundred day moving average price is $49.94. The company has a debt-to-equity ratio of 1.51, a quick ratio of 0.75 and a current ratio of 0.94. Exelon has a 52 week low of $31.25 and a 52 week high of $50.71.

Exelon (NASDAQ:EXCGet Rating) last announced its quarterly earnings data on Monday, May 9th. The company reported $0.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.01). Exelon had a return on equity of 10.87% and a net margin of 8.15%. During the same period in the prior year, the firm posted ($0.06) EPS. On average, equities research analysts forecast that Exelon will post 2.27 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 10th. Shareholders of record on Friday, May 13th will be issued a $0.3375 dividend. This represents a $1.35 dividend on an annualized basis and a yield of 2.89%. The ex-dividend date of this dividend is Thursday, May 12th. Exelon’s dividend payout ratio is 50.94%.

In other news, SVP Fabian Souza sold 21,400 shares of the stock in a transaction dated Friday, April 1st. The stock was sold at an average price of $47.61, for a total value of $1,018,854.00. Following the completion of the sale, the senior vice president now owns 2,337 shares of the company’s stock, valued at $111,264.57. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Carim V. Khouzami sold 3,962 shares of the firm’s stock in a transaction that occurred on Thursday, March 24th. The stock was sold at an average price of $44.35, for a total value of $175,714.70. The disclosure for this sale can be found here. Corporate insiders own 0.19% of the company’s stock.

Institutional investors have recently modified their holdings of the stock. Morgan Stanley grew its position in shares of Exelon by 6.6% in the second quarter. Morgan Stanley now owns 14,043,370 shares of the company’s stock valued at $622,261,000 after purchasing an additional 872,516 shares in the last quarter. First Trust Advisors LP raised its position in Exelon by 24.4% during the 1st quarter. First Trust Advisors LP now owns 2,730,711 shares of the company’s stock valued at $130,064,000 after purchasing an additional 535,957 shares during the last quarter. Deutsche Bank AG grew its holdings in shares of Exelon by 13.2% during the 4th quarter. Deutsche Bank AG now owns 2,188,933 shares of the company’s stock worth $126,431,000 after acquiring an additional 254,749 shares during the period. Bridgewater Associates LP grew its holdings in shares of Exelon by 540.1% during the 1st quarter. Bridgewater Associates LP now owns 262,758 shares of the company’s stock worth $12,515,000 after acquiring an additional 221,706 shares during the period. Finally, Federated Hermes Inc. grew its stake in shares of Exelon by 31.4% in the 1st quarter. Federated Hermes Inc. now owns 877,044 shares of the company’s stock worth $41,773,000 after buying an additional 209,531 shares during the last quarter. Institutional investors and hedge funds own 80.35% of the company’s stock.

Exelon Company Profile (Get Rating)

Exelon Corporation, a utility services holding company, engages in the energy generation, delivery, and marketing businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, biomass, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.

Recommended Stories

Earnings History and Estimates for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.